Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Cytology and HPV Testing Market to Cross US$ 10 Billion by 2024

Market Research Engine
Posted on: 25 Sep 16
Cytology and HPV Testing Market to Cross US$ 10 Billion by 2024

New York, September 29: Market Research Engine has published a new report titled as “Cytology and HPV Testing Market by Product and Services (Cytology Testing and HPV Testing) - Global Market Analysis, Trends and Forecast 2016 - 2024”

The Cytology and HPV testing market is expected to exceed more than USD 10 Billion by 2024. HPV testing market will grow at a CAGR of more than 10% in the given forecast period. While Cytology testing market will grow at a CAGR of around 5% from 2016 to 2024.

Download Free Sample Report:

What is Cytology and Human Papilloma Virus (HPV) Testing?

Cytology also called as cell biology and cytopathology in which study of cell composition, cell structure and the interaction among cells and the environment in which they exist. It also examines the cell structure which helps to diagnose disease. Human papilloma virus (HPV) is group of more than 100 related viruses. They can affect the moist membranes of body part such as anus, vagina, vulva and lining of the mouth and throat. It also affects the skin of human body, trachea, bronchi, inner nose, mouth and inner eyelids. All human papilloma viruses (HPV) in the group are specified a number called an HPV type. The implication of early diagnosis and detection is not lost on them resultant in the improved adoption of these tests such as cytology and HPV testing.

How Big is the Cytology and HPV testing market?

The Major Driving factors of cytology and HPV testing market are as follows:

Growing cervical cancer screening awareness plans
High occurrence rate of HPV infections
Increasing the amount of cervical cancer globally

The Restraining factors of Cytology and HPV testing market are as follows:

Low understanding of the global population
Need of correct primary healthcare infrastructure

Purchase Report From Here:

The cytology and HPV testing market is segmented on the lines of its product, service and by geography. Based on product and service segmentation the cytology and HPV testing market covers HPV testing and cytology testing. HPV testing is further segmented into services, assay kits and system. Based on cytology testing segment the market covers services, assay kits and system. The cytology and HPV testing market covers the  geographic segmentation in various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for cytology and HPV testing and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2021.

3) Identifications of new market opportunities and targeted promotional plans for cytology and HPV testing market.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.


The scope of the report includes a detailed study of global and regional markets for various types of cytology and HPV testing market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Becton, Dickinson and Company, Cepheid, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, Fujirebio Diagnostics, Inc., Arbor Vita Corporation, Hologic, Inc., QIAGEN N.V., and OncoHealth Corporation. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide the buyers with a snapshot of the industry’s most influential players.

The Cytology and HPV testing Market has been segmented as below:  

By Product and Services Analysis

HPV Testing
  Assay kits
Cytology Testing
  Assay kits

By Regional Analysis

North America
Rest of the World

For more information:

Editor's Details

John Bay
Market Research Engine

Last updated on: 29/09/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.